{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T06:34:01Z","timestamp":1722494041525},"reference-count":15,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.20945\/2359-3997000000129","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T15:00:35Z","timestamp":1556636435000},"source":"Crossref","is-referenced-by-count":1,"title":["The 4Ds of ectopic ACTH syndrome: diagnostic dilemmas of a difficult disease"],"prefix":"10.20945","author":[{"given":"Marcelo","family":"Vieira-Corr\u00eaa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9bora","family":"Moroto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Carpentieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Veras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio E.","family":"Kater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8510","published-online":{"date-parts":[[2019,4,15]]},"reference":[{"key":"key20190430150019_B1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing\u2019s syndrome","volume":"386","author":"Lacroix","year":"2015","unstructured":"1. Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing\u2019s syndrome. Lancet. 2015;386:913-27.","journal-title":"Lancet"},{"key":"key20190430150019_B2","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1210\/jc.2004-2527","article-title":"Cushing\u2019s syndrome due to ectopic corticotropin secretion: twenty years\u2019 experience at the National Institutes of Health","volume":"90","author":"Ilias","year":"2005","unstructured":"2. Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK. Cushing\u2019s syndrome due to ectopic corticotropin secretion: twenty years\u2019 experience at the National Institutes of Health. J Clin Endocrinol Metab. 2005;90:4955-62.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key20190430150019_B3","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1590\/S0004-27302012000500008","article-title":"A rare case of Cushing syndrome by cyclic ectopic-ACTH","volume":"56","author":"Farage","year":"2012","unstructured":"3. Farage M, Costa MADL, Godoy-Matos AF. A rare case of Cushing syndrome by cyclic ectopic-ACTH. Arq Bras Endocrinol Metab. 2012;56(5):324-30.","journal-title":"Arq Bras Endocrinol Metab"},{"issue":"1","key":"key20190430150019_B4","first-page":"42","article-title":"Cushing\u2019s syndrome due to ectopic ACTH. Contribution of the somatostatin receptor scintigraphy","volume":"31","author":"Del Valle-Torres","year":"2012","unstructured":"4. Del Valle-Torres MDM, Amrani-Raissouni T, Moya-Espinosa P, Jim\u00e9nez-Hoyuela JMG. Cushing\u2019s syndrome due to ectopic ACTH. Contribution of the somatostatin receptor scintigraphy. Rev Esp Med Nucl Imagen Mol. 2012;31(1):42-3.","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"issue":"3","key":"key20190430150019_B5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4103\/1450-1147.144823","article-title":"Gallium-68 DOTA-TATE positron emission tomography\/computed tomography: Scintigraphic changes of adrenal glands following management of ectopic Cushing\u2019s syndrome by steroidogenesis inhibitors","volume":"13","author":"Huang","year":"2014","unstructured":"5. Huang Y-T, Aziz SI, Kumar ASR. Gallium-68 DOTA-TATE positron emission tomography\/computed tomography: Scintigraphic changes of adrenal glands following management of ectopic Cushing\u2019s syndrome by steroidogenesis inhibitors. World J Nuclear Med. 2014;13(3):201-4.","journal-title":"World J Nuclear Med"},{"issue":"7","key":"key20190430150019_B6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1590\/S0004-27302012000700009","article-title":"Ectopic Cushing\u2019s syndrome caused by a pulmonary ACTH-secreting tumor in a patient treated with octreotide","volume":"56","author":"Rodrigues","year":"2012","unstructured":"6. Rodrigues P, Castedo JL, Damasceno M, Carvalho D. Ectopic Cushing\u2019s syndrome caused by a pulmonary ACTH-secreting tumor in a patient treated with octreotide. Arq Bras Endocrinol Metab. 2012;56(7):461-4.","journal-title":"Arq Bras Endocrinol Metab"},{"key":"key20190430150019_B7","article-title":"A challenging case of an ectopic Cushing syndrome","volume":"2014","author":"Nunes","year":"2014","unstructured":"7. Nunes JM, Pinho E, Cam\u00f5es I, Maciel J, Bastos PC, Moura CS, et al. A challenging case of an ectopic Cushing syndrome. Case Rep Med. 2014;2014:413136.","journal-title":"Case Rep Med"},{"key":"key20190430150019_B8","first-page":"533","article-title":"The hypoplastic inferior petrosal sinus: A potential source of false-negative results in petrosal sampling for Cushing\u2019s disease","volume":"84","author":"Doppman","year":"1999","unstructured":"8. Doppman JL, Chang R, Oldfield EH, Chrousos G, Stratakis CA, Nieman LK. The hypoplastic inferior petrosal sinus: A potential source of false-negative results in petrosal sampling for Cushing\u2019s disease. J Clin Endocrinol Metab. 1999;84:533-40.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"key20190430150019_B9","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1210\/JC.2015-1589","article-title":"Conventional and nuclear medicine imaging in ectopic Cushing\u2019s syndrome: A systematic review","volume":"100","author":"Isidori","year":"2015","unstructured":"9. Isidori AM, Sbardella E, Zatelli MC, Boschetti M, Vitale G, Colao A, et al. Conventional and nuclear medicine imaging in ectopic Cushing\u2019s syndrome: A systematic review. J Clin Endocrinol Metab. 2015;100(9):3231-44.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20190430150019_B10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11154-010-9139-z","article-title":"The ectopic ACTH syndrome","volume":"11","author":"Alexandraki","year":"2010","unstructured":"10. Alexandraki KI, Grossman AB. The ectopic ACTH syndrome. Rev Endocr Metab Disord. 2010;11:117-26.","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"key20190430150019_B11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3390\/cancers4030777","article-title":"Neuroendocrine Tumors of the Lung","author":"Fisseler-Eckhoff","year":"2012","unstructured":"11. Fisseler-Eckhoff A, Demes M. Neuroendocrine Tumors of the Lung. Cancers (Basel). 2012; (4):777-98.","journal-title":"Cancers (Basel)"},{"issue":"23","key":"key20190430150019_B12","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJM200506093522322","article-title":"Cabergoline plus lanreotide for ectopic Cushing\u2019s syndrome","volume":"352","author":"Pivonello","year":"2005","unstructured":"12. Pivonello R, Ferone D, Lamberts SW, Colao A. Cabergoline plus lanreotide for ectopic Cushing\u2019s syndrome. N Engl J Med. 2005;352(23):2457-8.","journal-title":"N Engl J Med"},{"issue":"5","key":"key20190430150019_B13","doi-asserted-by":"crossref","first-page":"829","DOI":"10.4158\/EP09286.CR","article-title":"Long-term management with octreotide or cabergoline in ectopic corticotropin hypersecretion: case report and literature review","volume":"16","author":"Bruno","year":"2010","unstructured":"13. Bruno OD, Danilowicz K, Manavela M, Mana D, Rossi MA. Long-term management with octreotide or cabergoline in ectopic corticotropin hypersecretion: case report and literature review. Endocr Pract. 2010;16(5):829-34.","journal-title":"Endocr Pract"},{"key":"key20190430150019_B14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000314292","article-title":"Medical treatment of Cushing\u2019s syndrome: adrenal-blocking drugs and ketaconazole","volume":"92","author":"Feelders","year":"2010","unstructured":"14. Feelders RA, Hofland LJ, de Herder WW. Medical treatment of Cushing\u2019s syndrome: adrenal-blocking drugs and ketaconazole. Neuroendocrinology. 2010;92(suppl1):111-5.","journal-title":"Neuroendocrinology"},{"key":"key20190430150019_B15","volume-title":"Bronchial Neuroendocrine (carcinoid) Tumors: Treatment and Prognosis","author":"Thomas","year":"2017","unstructured":"15. Thomas CF, Jett JR, Strosberg JR. In: Bronchial Neuroendocrine (carcinoid) Tumors: Treatment and Prognosis. UpToDate, Post TW, editors. UpToDate: Waltham, MA. 2017. (Accessed on 15 April 2017)"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T15:00:46Z","timestamp":1556636446000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2359-39972019005002109&lng=en&nrm=iso"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,15]]},"references-count":15,"alternative-id":["10.20945\/2359-3997000000129"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000129","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,15]]}}}